Phase 1 trials are usually open to various types of tumors.
Having a measurable disease, which means it can be scanned and accurately measured by an experienced radiologist.
Having received standard therapy.
This scale is a prognostic factor and determines a patient’s ability for therapy toleration. These numbers stand for:
Having an adequate renal and organ function.
Able to undergo a biopsy of the tumor or metastasis.
You can find more information on how to register for a clinical trial on this page.